TD Cowen boosted its price target and gave a buy rating for Jazz Pharmaceuticals.

1 report, 1 independent Updated Thu 00:00

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Jazz Pharmaceuticals TD Cowen

Keep exploring

Part of

Analyst coverage and company performance data published regarding Jazz Pharmaceuticals, involving MarketBeat, Royal Bank of Canada, and TD Cowen. All 1 developments

The entities involved

Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
- Jazz Pharmaceuticals relocated its headquarters to Ireland while an aggressive tariff plan caused markets to tank.Mon 23:11
- Jazz Pharmaceuticals plans U.S. launch of Ziihera.Mon 23:03
TD Cowen
American investment bank
- TD Cowen and Susquehanna raised ratings and price targets for Marvell Technology.09:50
- TD Cowen cut its price target for Federated Hermes, while Royal Bank of Canada raised its price target for the company.09:21

Related events

Coverage

Newest first; wire copies grouped

Thu 00:00dailypolitical.com